The Chemours Company beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses), averaging -2.3% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.43 | $0.42 | -2.3% | Miss | Q2 FY26 call |
| Q1 FY26 | not reported | $0.05 | not reported | not reported |
Back to CC overview · CC holders · CC KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.